168 related articles for article (PubMed ID: 9164443)
1. Clinical promise of tumour immunology.
Scott AM; Cebon J
Lancet; 1997 May; 349 Suppl 2():SII19-22. PubMed ID: 9164443
[No Abstract] [Full Text] [Related]
2. Anti-tumor immune response.
Hainaut P
Acta Clin Belg; 1993; 48(2):73-80. PubMed ID: 8392247
[No Abstract] [Full Text] [Related]
3. [Tumor vaccination using monoclonal antibodies].
Veelken H
Internist (Berl); 2001 Jun; 42(6):874-83. PubMed ID: 11449634
[No Abstract] [Full Text] [Related]
4. CTLA-4 blockade: autoimmunity as treatment.
Kapadia D; Fong L
J Clin Oncol; 2005 Dec; 23(35):8926-8. PubMed ID: 16204008
[No Abstract] [Full Text] [Related]
5. A cancer-fighting implant?
Marron K
Lab Anim (NY); 2009 Mar; 38(3):72. PubMed ID: 19229213
[No Abstract] [Full Text] [Related]
6. Cancer vaccines.
Liu MA
Philos Trans R Soc Lond B Biol Sci; 2011 Oct; 366(1579):2823-6. PubMed ID: 21893546
[TBL] [Abstract][Full Text] [Related]
7. [Perspectives for tumour immunology: antigen-specific immunotherapy of malignant diseases].
Jäger E; Jäger D; Knuth A
Dtsch Med Wochenschr; 2001 Sep; 126(37):1011-6. PubMed ID: 11555776
[No Abstract] [Full Text] [Related]
8. [Monoclonal antibodies and cancer].
López González JS; Selman Lama M
Salud Publica Mex; 1985; 27(3):213-34. PubMed ID: 2996157
[No Abstract] [Full Text] [Related]
9. Immunotherapy at large: the road to personalized cancer vaccines.
Vonderheide RH; Nathanson KL
Nat Med; 2013 Sep; 19(9):1098-100. PubMed ID: 24013748
[No Abstract] [Full Text] [Related]
10. The genealogy of SEREX.
Pfreundschuh M
Cancer Immun; 2012; 12():7. PubMed ID: 22896752
[No Abstract] [Full Text] [Related]
11. Potential clinical utility of monoclonal antibodies in the management of human carcinomas.
Schlom J; Weeks MO
Important Adv Oncol; 1985; ():170-92. PubMed ID: 3916739
[No Abstract] [Full Text] [Related]
12. An introduction to tumour immunology.
James K
Arch Immunol Ther Exp (Warsz); 1983; 31(6):795-808. PubMed ID: 6611141
[TBL] [Abstract][Full Text] [Related]
13. [Immunology of cancer].
Abelev GI
Vestn Ross Akad Med Nauk; 1999; (4):21-5. PubMed ID: 10377879
[TBL] [Abstract][Full Text] [Related]
14. The revival of cancer vaccines - The eminent need to activate humoral immunity.
Huijbers EJM; Griffioen AW
Hum Vaccin Immunother; 2017 May; 13(5):1112-1114. PubMed ID: 28118089
[TBL] [Abstract][Full Text] [Related]
15. Guest editorial: Cancer immunology.
Yasukawa M
Int J Hematol; 2011 Mar; 93(3):261-262. PubMed ID: 21347643
[No Abstract] [Full Text] [Related]
16. [Immunological problems in oncology (author's transl)].
Petruzzelli C; Comotti F; Pugnani M; Sacchi L; Cereser M
Ann Sclavo; 1979; 21(4):502-44. PubMed ID: 95475
[TBL] [Abstract][Full Text] [Related]
17. Cellular and humoral immune responses against cancer: implications for cancer vaccines.
Knuth A; Wölfel T; Meyer zum Büschenfelde KH
Curr Opin Immunol; 1991 Oct; 3(5):659-64. PubMed ID: 1755985
[TBL] [Abstract][Full Text] [Related]
18. [Antigens and antigenic systems].
Cordón-Cardo C; Graus F
Med Clin (Barc); 1987 Mar; 88(9):381-7. PubMed ID: 3553765
[No Abstract] [Full Text] [Related]
19. Basic principles and applications of monoclonal antibodies in the management of carcinomas: the Richard and Hinda Rosenthal Foundation award lecture.
Schlom J
Cancer Res; 1986 Jul; 46(7):3225-38. PubMed ID: 3518915
[No Abstract] [Full Text] [Related]
20. Progress in vaccination against cancer (PIVAC) 2001, Robinson College, University of Cambridge, UK.
Rees RC; Pawelec G; Müller L; Robins A
Cancer Immunol Immunother; 2002 Mar; 51(1):58-61. PubMed ID: 11845261
[No Abstract] [Full Text] [Related]
[Next] [New Search]
